CANNABISHUB:EUMedical cannabis research platform

conditions cannabinoids studies medicines library about

Loading organization profile…

Anonymous aggregate analytics use the connection IP transiently only to derive country; the IP is not stored in analytics data. DNT and GPC are honored, with 90-day retention. IP Geolocation by DB-IP.

Queen Mary University of London - Medical Cannabis Research Engine

CANNABISHUB:EUMedical cannabis research platform

conditions cannabinoids studies medicines library about

Organizations/education

education organization

Queen Mary University of London

GB

OPENALEX: I166337079↗ROR: 026zzn846↗

People

Connected researchers

Artemis IgoumenouORCID 0000-0002-6790-208X David BakerORCID 0000-0002-8872-8711 Giulia MastroianniExact authorship link James RuffleORCID 0000-0001-6248-7203 Joaquin BottaORCID 0000-0001-6450-1267 Jonathan P RoiserORCID 0000-0001-8269-1228 Kamaldeep BhuiORCID 0000-0002-9205-2144 Peter J. McCormickORCID 0000-0002-2225-5181 Stephanie TaylorORCID 0000-0001-7454-6354

Public evidence

4 connected articles

Identification of BiP as a CB<sub>1</sub> Receptor-Interacting Protein That Fine-Tunes Cannabinoid Signaling in the Mouse Brain.2021 · PubMed Central Open Access Cannabidiol Is a Novel Modulator of Bacterial Membrane Vesicles.2019 · Europe PMC Salience attribution and its relationship to cannabis-induced psychotic symptoms.2016 · PubMed Central Open Access How Cannabis Causes Paranoia: Using the Intravenous Administration of ∆9-Tetrahydrocannabinol (THC) to Identify Key Cognitive Mechanisms Leading to Paranoia2015 · PubMed Central Open Access

Matched by exact identifiers only. Profile data: OpenAlex.